BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10773967)

  • 41. Evidence for functional discrimination between leukemic cells overexpressing multidrug-resistance associated protein and P-glycoprotein.
    Benderra Z; Morjani H; Trussardi A; Manfait M
    Adv Exp Med Biol; 1999; 457():151-60. PubMed ID: 10500790
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
    Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
    Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
    Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
    Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced expressions of Fas and Bcl-2 proteins in CD14+ monocytes and normal CD14 soluble levels in juvenile systemic lupus erythematosus.
    Liphaus BL; Kiss MH; Carrasco S; Goldenstein-Schainberg C
    Lupus; 2013 Aug; 22(9):940-7. PubMed ID: 23846229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of Aiolos in Peripheral Blood Mononuclear Cell Subsets from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Cai X; Liu X; Du S; Xu X; Liu A; Ge X; Qiao Y; Jiang Y
    Biochem Genet; 2016 Feb; 54(1):73-82. PubMed ID: 26546109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lack of involvement of P-glycoprotein (P-gp) in pemphigus patients with poor response to steroid therapy.
    de la Fuente H; Baranda L; Hernández MI; Torres-Alvarez B; Llorente L; Layseca E; González-Amaro R
    J Dermatol Sci; 2002 Apr; 28(3):219-26. PubMed ID: 11912009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. P-glycoprotein in autoimmune rheumatic diseases.
    García-Carrasco M; Mendoza-Pinto C; Macias Díaz S; Vera-Recabarren M; Vázquez de Lara L; Méndez Martínez S; Soto-Santillán P; González-Ramírez R; Ruiz-Arguelles A
    Autoimmun Rev; 2015 Jul; 14(7):594-600. PubMed ID: 25712147
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The multidrug resistance phenotype confers immunological resistance.
    Weisburg JH; Curcio M; Caron PC; Raghu G; Mechetner EB; Roepe PD; Scheinberg DA
    J Exp Med; 1996 Jun; 183(6):2699-704. PubMed ID: 8676093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy.
    Durcan L; Winegar DA; Connelly MA; Otvos JD; Magder LS; Petri M
    J Rheumatol; 2016 Apr; 43(4):745-50. PubMed ID: 26834214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
    Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
    Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
    Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells.
    Laupèze B; Amiot L; Bertho N; Grosset JM; Lehne G; Fauchet R; Fardel O
    Hum Immunol; 2001 Oct; 62(10):1073-80. PubMed ID: 11600213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.
    Takeshita A; Shinjo K; Ohnishi K; Ohno R
    Jpn J Cancer Res; 1995 Jun; 86(6):607-15. PubMed ID: 7622426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia.
    Pallis M; Turzanski J; Harrison G; Wheatley K; Langabeer S; Burnett AK; Russell NH
    Br J Haematol; 1999 Feb; 104(2):307-12. PubMed ID: 10050713
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
    Takasaki Y; Ogaki M; Abe K; Takeuchi K; Ando S; Tokano Y; Kobayashi S; Sekigawa I; Tsuda H; Hashimoto H
    J Rheumatol; 1998 Jun; 25(6):1085-91. PubMed ID: 9632068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decreased arachidonic acid release in peripheral blood monocytes of patients with systemic lupus erythematosus.
    Sipka S; Szántó S; Szucs K; Kovács I; Kiss E; Antal-Szamás P; Lakos G; Aleksza M; Illés A; Gergely P; Szegedi G
    J Rheumatol; 2001 Sep; 28(9):2012-7. PubMed ID: 11550968
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multidrug resistance in the laboratory and clinic.
    Bellamy WT; Dalton WS
    Adv Clin Chem; 1994; 31():1-61. PubMed ID: 7879670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.